David J. Wright

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Susan Dent, Susannah Stanway et al. · European Journal of Heart Failure · 2020 · 717 citations · Full text

Antibacterial Envelope to Prevent Cardiac Implantable Device Infection

Khaldoun G. Tarakji, Suneet Mittal, Charles Kennergren et al. · New England Journal of Medicine · 2019 · 370 citations · Full text

Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial

Michael R. Gold, Pier D. Lambiase, Mikhael F. El‐Chami et al. · Circulation · 2020 · 211 citations · Full text

Comparison of Long-Term Outcomes of Atrial Repair of Simple Transposition With Implications for a Late Arterial Switch Strategy

David Sarkar, Catherine Bull, Robert Yates et al. · Circulation · 1999 · 144 citations

Atorvastatin but not l-arginine improves endothelial function in type I diabetes mellitus: a double-blind study

Michael Mullen, David J. Wright, Ann E. Donald et al. · Journal of the American College of Cardiology · 2000 · 129 citations

Metabolic Syndrome, Hypertension, Vascular Disease +10